Company intelligence / Profile preview

Energy

Tokyo, Tokyo, Japan

Ownership: Private
Development stage: Other

Overview

Energy is a Japanese pharmaceutical and biotechnology company that focuses on the development and commercialization of products targeting energy metabolism and mitochondrial health. The company is best known for its work in metabolic disorders and aging-related conditions, leveraging scientific insights into cellular energetics to create therapeutic solutions. Energy operates primarily in the Japanese market but has established a presence in the broader life sciences sector through its specialized product portfolio. Its business model encompasses the research, development, and distribution of both pharmaceutical agents and health-related supplements designed to optimize cellular function.

Therapeutic areas: NeurologyOtherMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Energy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Energy.

Explore the full profile